Quantification of soluble serum HLA class I antigens in healthy volunteers and AIDS patients. NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Quantification of soluble serum HLA class I antigens in healthy volunteers and AIDS patients.

Clin Chim Acta. 1988 May 31;174(2):207-11. Unique Identifier : AIDSLINE MED/88253836
Ferreira A; Villar ML; Alvarez Cermeno JC; Revilla Y; Garcia Rodriguez MC; Fontan G; Gonzalez-Porque P; Unidad de Immunologia, Ciudad Sanitaria La Paz, Madrid, Spain.


Abstract: A solid-phase enzyme immunoassay (ELISA) has been used to quantify human soluble Class I histocompatibility antigens in serum samples from voluntary blood donors and AIDS patients. Statistical analysis of the results showed significantly raised levels (p less than 0.01) of free HLA Class I in sera from AIDS patients (2.95 +/- 1.80 micrograms/ml) when compared with the blood donors (1.06 +/- 0.6 micrograms/ml). The assay is specific, reproducible and easy to perform. Potential uses of this determination are discussed.
Keywords: Acquired Immunodeficiency Syndrome/BLOOD/*IMMUNOLOGY *Blood Donors Comparative Study Enzyme-Linked Immunosorbent Assay Human HLA Antigens/*ANALYSIS JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/blood/KWDimmunologyKWDblooddonorscomparativestudyenzyme-linkedimmunosorbentassayhumanhlaantigens/KWDanalysisjournalarticle
881030
M88A0599


Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .